MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10
Published May 22, 2024 · Recall initiated: April 25, 2024
Summary
FDA records drug Class II recall D-0499-2024, published May 22, 2024 and initiated April 25, 2024. Recalling firm: Sagent Pharmaceuticals; Status: Ongoing; Reported quantity: 14,360 vials; Lot: Lots 5100186, 5100187, 5100188, 5100189, Exp 01/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Potential for black particulates in the drug product.
What to do
Voluntary: Firm initiated · Letter
Get an email if METHYLPREDNISOLONE ACETATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHYLPREDNISOLONE ACETATE
- Manufacturer
- Sagent Pharmaceuticals
- Distributor
- Nationwide in the USA
- Lot
- Lots 5100186, 5100187, 5100188, 5100189, Exp 01/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALosartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only,May 22, 2024
- FDACVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Cherry Flavor, 10 fl. oz bottle,May 22, 2024
- FDACefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, ManufacturedMay 22, 2024
- FDAMeijer Magnesium Citrate Saline Laxative Oral Solution Dye Free, Sugar Free Grape, 10 fl. oz bottle,May 22, 2024
- FDACefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, ManufacturedMay 22, 2024
- FDAMethylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, RxMarch 13, 2024
Questions about this recall
Was MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10 recalled?
Yes. FDA published recall D-0499-2024 on May 22, 2024. Reported hazard: Presence of Particulate Matter: Potential for black particulates in the drug product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHYLPREDNISOLONE ACETATE.